STUDY SUMMARY
Lung Cancer Model: J000100672
NSG™ mice engrafted with passage 4 tumors for model J000100672
were randomly assigned to one of these treatment groups:
- Control group (no treatment; N=8)
- Cisplatin (2 mg/kg; IV once per week for three times; N=7)
- Erlotinib (50 mg/kg; PO daily for 21 days; N=9)
Mice were monitored for tumor volume at least twice per week throughout the study period.
• Treatment groups
• Individual subjects / spider plot
• RECIST scores
• Waterfall plot
• TGI plot
• Protocols
Hide/show treatment groups
Hide/show treatment groups
Hide/show treatment groups